LivingGLP1
Study S002725

Effect of Cycloset on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled on GLP-1 Analogue Therapy

Registration

Registration
NCT02299050
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
23
Start
2014-06
Primary completion
2018-04-30
Lead sponsor
The University of Texas Health Science Center at San Antonio
Conditions
Type 2 Diabetes
Interventions
DRUG:Cycloset
Results posted
TRUE

Registered primary outcomes

  • HbA1C [Change from baseline to four to five months]
  • Glucose Metabolism During Mixed Meal Tolerance Test [Change from baseline to four to five months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.